• Cell-Infused Wearable Sensors Aim to Detect Infection and Disease

    A new "living material" is designed with live cells that can be genetically programmed to light up in the presence of certain chemicals, bacteria, and possibly even biomarkers for disease. Kristopher SturgisShown are the cell-infused sensors in glove and bandage form.A group of engineers and biologists from MIT announced this week the design of a new wearable material infused with live cells that can be genetically programmed to light up and glow when the cells come into contact with...
  • IBM Watson Health’s Dramatic Expansion

    Cognitive computing powerhouse IBM Watson Health is adding novel offerings and entering new agreements in an array of healthcare arenas.Marie ThibaultThis week, IBM Watson Health announced a slew of solutions and partnerships aimed at improving healthcare decision making and delivery. The announcement, which was released during a major gathering for the health IT community—the annual Healthcare Information and Management Systems Society (HIMSS) conference—covers offerings focused on value-...
  • How Edwards Is Getting Its Groove Back With CardiAQ

    After a three-week enrollment pause for additional design validation testing, Edwards Lifesciences is ready to get its CardiAQ transcatheter mitral valve replacement (TMVR) program back on track. But the path forward could still be a long one for TMVR in general, according to one medtech analyst. Amanda PedersenThe Edwards CardiaAQ transcatheter mitral valve is ready for clinical trials following the company's voluntary enrollment pause, during which it completed additional...
  • U.S. Panel Supports Use of CRISPR to Genetically Modify Human Embryos

    The National Academy of Sciences has become the first major institution to endorse the use of gene-editing technology in human embryos to prevent the birth of children with serious diseases.Kristopher SturgisA diagram of the CRISPR prokaryotic viral defense mechanism.The National Academy of Sciences, one of the nation’s most influential science advisory groups, announced its support for the use of CRISPR to modify human embryos in a series of heritable germline genome editing trials. The...
  • IBM Watson Health’s Dramatic Expansion

    Cognitive computing powerhouse IBM Watson Health is adding novel offerings and entering new agreements in an array of healthcare arenas.Marie ThibaultThis week, IBM Watson Health announced a slew of solutions and partnerships aimed at improving healthcare decision making and delivery. The announcement, which was released during a major gathering for the health IT community—the annual Healthcare Information and Management Systems Society (HIMSS) conference—covers offerings focused on value-based...
  • New Magnetic Implant Offers Controlled Drug Delivery

    Canadian researchers have created a new implantable device that can be triggered to release drugs by passing a magnet over the device outside the skin. Kristopher SturgisShown is an image of the magnetic implant next to the Canadianone-dollar coin. A new implantable drug delivery device was revealed last week by researchers from the University of British Columbia that could be used as an alternative for patients who rely on a high number of pills or intravenous injections for...
  • How A New AI Diabetes System Outperformed Top Docs

    Aspire Ventures pitted its adaptive artificial intelligence platform, A2I, against some of Europe's best diabetes specialists in an observational trial and the A2I won.Amanda Pedersen  A diabetes management system built on a new artificial intelligence platform proved it could offer people with diabetes a less invasive and more personalized solution for managing their blood glucose levels.Diabeter, a Netherlands-based diabetes clinic and research center that Medtronic bought in...
  • 3 Must-Have Features for Mobile Medical Devices

    Are your devices tough enough?Daphne AllenThere’s a trend toward mobile medical equipment today, observes Josh Blackmore, Global Healthcare Manager at RTP Company. “People are bringing medical technology to the patient,” he told Qmed at MD&M West. “Why move a sick patient?”Mobile equipment for ultrasound and x-ray procedures is being developed, as are mobile pharmacies and other devices, Blackmore noted. “There’s definitely a trend toward putting equipment on wheels,” he added. Such...
  • Is Integra's J&J Deal Risky Business?

    Integra Lifesciences made a $1.05 billion offer for Johnson & Johnson’s Codman Neurosurgery business, but some analysts see it as a risky move.Amanda Pedersen Valentine’s Day may have just been one day, but medtech has been showing the love all week long — for deals, that is.Integra Lifesciences Holdings Corp. was the third company in as many days this week to announce a billion-dollar acquisition. The company said it plans to pay Johnson & Johnson about $1.05 billion in cash for...
  • High Failure Rate Forces Zimmer Biomet To Recall Shoulders

    FDA said a shoulder replacement device recalled by Zimmer Biomet is considered a Class I recall. The device is being recalled due to a high rate of fractures. Amanda PedersenZimmer Biomet recalled its Comprehensive Reverse Shoulder device due to a high rate of fractures. FDA identified the recall Thursday as a Class I, the most serious type of recall. A high fracture rate forced Zimmer Biomet to recall its 3,662 of its Comprehensive Reverse Shoulder devices, and FDA classified...
  • Why Hologic’s Big Deal Threw Investors For A Loop

    Analysts were caught off guard by Hologic’s $1.65 billion proposal to buy aesthetic company Cynosure. Amanda Pedersen  Hologic Inc. threw analysts and investors for a loop this week with its $1.65 billion proposal to buy aesthetic technology maker Cyosure Inc., a deal that would place Hologic in a new, albeit fast-growing cash-pay segment.If all goes according to plan, the acquisition will close in April. At $66 a share, the deal has an equity value of about $1.65 billion and an...
  • Here's The Scoop On Scopis Scoping U.S. Market

    Scopis recently opened an office in Cambridge and is cultivating investors in the U.S.Nancy CrottiScopis offers target-guided surgery via augmented reality. A German company that sells augmented reality products for minimally invasive surgery has landed in the United States.Founded in 2010, Scopis GmbH offers augmented reality software to help surgeons plan ENT, craniomaxillofacial, neurological, spinal, and bronchoscopic procedures. The company’s...
  • ADM Cleveland Innovation Prize Official Rules

    NO PURCHASE OR PAYMENT OF ANY KIND IS NECESSARY TO ENTER OR WIN. A PURCHASE OR PAYMENT WILL NOT IMPROVE YOUR CHANCES OF WINNING. CONTEST IS VALID ONLY IN THE UNITED STATES (EXCLUDING PUERTO RICO) AND CANADA (EXCLUDING QUEBEC) – ENTRIES FROM PERSONS LIVING IN OTHER COUNTRIES WILL BE AUTOMATICALLY DISQUALIFIED. GENERAL CONDITIONS:The ADM Cleveland Innovation Prize (the “Contest”) is sponsored by UBM LLC, 2901 28th St., Ste. 100, Santa Monica, CA 90405 (“UBM” or “...
  • Call for Entries: ADM Cleveland 2017 Innovation Prize

    If you'll be showcasing an innovative medtech product or service at the upcoming Advanced Design & Manufacturing Cleveland expo March 29–30, enter our contest for a chance to be included in a special innovation tour for attendees. Entries are due February 24, 2017.UBM is looking to identify the most innovative exhibitors at Advanced Design & Manufacturing Cleveland and give them the recognition they deserve. The ADM Cleveland Innovation Prize is a contest acknowledging the most...
  • Allergan Wants To Sculpt Out Part Of A $4B Market

    Allergan wants to buy aesthetic device company Zeltiq for $2.47 billion, a deal that would give the biopharmaceutical giant a strong position in body contouring, a $4 billion global market opportunity. Amanda Pedersen  Allergan has been placing big bets on the fast-growing medical aesthetics sector. Earlier this month the Dublin-based biopharmaceutical company pumped up its regenerative medicine offering with a $2.9 billion cash purchase of Branchburg, NJ-based LifeCell Corp....
  • FDA Picks Up Bad Vibe From Vibrator Marketing

    FDA warns Rapid Release Technologies that its therapeutic vibrator, which has not gone through the agency’s regulatory approval process, is considered a medical device based on its intended uses. The company said it is working with FDA and consultants to comply with FDA labeling requirements. Updated February 14, 2017 Amanda Pedersen Therapeutic vibrators and heating pads are generally exempt from FDA’s premarket approval requirements, but Rapid Release Technologies' marketing...
  • Does M&A Beat Organic Innovation?

    A panel of experts at MD&M West weighed in on acquisition-based innovation vs. organic innovation for growing a successful company.Amanda Pedersen Is it smarter to scale innovation organically or through M&A? Bryce Rutter challenged experts with that question last week during a panel he moderated at MD&M West on the subject of "Keeping Innovation at the Heart of Product Development."The question was particularly timely as mass consolidation continues to be a prevalent...
  • How To Design Winning Devices With Front-End Research

    A panel of product design experts discuss the importance of front-end research and the reality that what people say they do often differs from how they really behave.Amanda Pedersen As an expert in integrating research, ergonomics, and design into new product development, Bryce Rutter knows all too well that what people say they do typically differs from how they really behave. That’s why relying on focus groups for medical device design doesn’t usually work, he said during a panel...
  • Tom Price Confirmed as HHS Head

    The Senate voted to confirm Price as secretary of the Department of Health and Human Services. Here's what to expect.Marie ThibaultTom Price, MD is in as secretary of the Department of Health and Human Services (HHS) after the U.S. Senate voted 52-47 to confirm his nomination. The post of HHS head is particularly key as Republicans look to oust the Affordable Care Act (ACA).Senators voted along party lines, with all Republicans—and no Democrats—voting to confirm.Price, a Republican congressman...
  • How To Make Sensors That Make Sense

    An IoT expert talks about what works and what doesn't work in the rapidly-growing world of sensor technologyAmanda Pedersen When it comes to developing sensor-based products, it's okay to get a bit crazy, as long as the end product conforms to five guiding design principals. At least, that's what Mark Bachman, an Internet of Things (IoT) Evangelist, and a professor at the University of California Irvine, tells his students.At MD&M West, Bachman, who also is director of the eHealth...